SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Barth Jay Allan

(Last)

(First)

(Middle)

PTC THERAPEUTICS, INC.

100 CORPORATE COURT

(Street)

SOUTH PLAINFIELD

07080

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/19/2013

3. Issuer Name and Ticker or Trading Symbol
PTC THERAPEUTICS, INC. [ PTCT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Clinical Development

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,387	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	⁽¹⁾	05/15/2023	Common Stock	15,000	$10.85	D
Stock Option (right to buy)	⁽²⁾	05/15/2023	Common Stock	40,000	$10.85	D
Stock Option (right to buy)	⁽³⁾	01/10/2022	Common Stock	133	$218.4	D
Stock Option (right to buy)	⁽⁴⁾	04/27/2021	Common Stock	183	$490.8	D
Stock Option (right to buy)	⁽⁵⁾	02/02/2020	Common Stock	62	$1,149.6	D
Stock Option (right to buy)	⁽⁶⁾	05/15/2019	Common Stock	166	$451.2	D

Explanation of Responses:

1. This option was granted on May 15, 2013 and vests over four years, subject to achievement of specified performance objectives, with 25% of the shares underlying the option vesting on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.

2. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vesting on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.

3. This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2013.

4. This option was granted on April 27, 2011 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2012 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2012.

5. This option was granted on February 2, 2010 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2011 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2011.

6. Currently exercisable.

Remarks:

Exhibit Index: 24.1 Power of Attorney

	/s/ Jay Barth	06/19/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.